ℹ️ Compiled from public regulatory records · Last regulator revision: August 1, 2025🚩 Report this page
Poloxamer 188
Active ingredient
Sold as DANLAX SUSPENSION
GB MHRA
- Drug class
- -
- Availability
- See label
- Markets covered
- 1
- Products on record
- 1
Overview
Poloxamer 188 is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | August 1, 2025 |
GBUnited Kingdom· MHRA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Brands in United Kingdom (1)
Sources & citations
- [1]MHRA (UK) · PL204160686 · revised August 1, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.